Sonoma Pharmaceuticals SNOA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 3.07 | 183.59 | -0.46 | -850 | -1 | |
| 2024Q2 | 4.24 | 117.65 | -1.40 | -1,173 | -1 | |
| 2024Q1 | 3.33 | 103.68 | 0.20 | -1,409 | -1 | |
| 2023Q4 | 3.61 | 91.44 | 0.67 | -844 | -1 | |
| 2023Q3 | 15.44 | 93.07 | -5.67 | -1,208 | -1 | |
| 2023Q2 | 21.40 | 85.46 | -5.80 | -1,240 | -1 | |
| 2023Q1 | 19.53 | 78.83 | -5.60 | -1,147 | -1 | |
| 2022Q4 | 22.40 | 96.18 | -12.60 | -1,837 | -2 | |
| 2022Q3 | 42.60 | 79.46 | -6.40 | -731 | -1 | |
| 2022Q2 | 58.40 | 92.73 | -5.80 | -855 | -1 | |
| 2022Q1 | 80.20 | 93.49 | -21.40 | -3,060 | -3 | |
| 2021Q4 | 91.20 | 101.16 | -6.20 | -958 | -1 | |
| 2021Q3 | 111.60 | 1060.44 | -0.40 | -965 | 0 | |
| 2021Q2 | 146.80 | 82.41 | -10.40 | -904 | -1 | |
| 2021Q1 | 148.60 | 104.03 | -36.40 | -2,814 | -4 | |
| 2020Q4 | 145.20 | 22.79 | -6.40 | -139 | -1 | |
| 2020Q3 | 167.40 | 106.96 | 0.80 | 169 | 0 | |
| 2020Q2 | 142.40 | 94.06 | 2.60 | -665 | 0 | |
| 2020Q1 | 98.00 | 251.00 | -22.00 | -2,505 | -1 | |
| 2019Q4 | 87.20 | 91.65 | -15.40 | -1,108 | -1 |